Novavax Appoints GSK's Bob Darius SVP Quality Operations
This article was originally published in Scrip
Vaccine company Novavax Inc. has appointed Bob Darius senior vice president of quality operations. Darius was previously vice president of quality operations at GlaxoSmithKline Biologicals and most recently transitioned to head quality advocacy liaison. He also held various positions of increasing responsibility at the FDA's Center for Biologics Evaluation and Research, where he was a senior reviewer and inspector and advisor to the deputy center director of medicine on counter-bioterrorism products.